Prestige Consumer Healthcare Inc. reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was USD 286.31 million compared to USD 289.26 million a year ago. Revenue was USD 286.32 million compared to USD 289.27 million a year ago. Net income was USD 53.56 million compared to USD 51.02 million a year ago. Basic earnings per share from continuing operations was USD 1.08 compared to USD 1.02 a year ago. Diluted earnings per share from continuing operations was USD 1.07 compared to USD 1.02 a year ago.
For the six months, sales was USD 565.61 million compared to USD 566.29 million a year ago. Revenue was USD 565.63 million compared to USD 566.33 million a year ago. Net income was USD 106.84 million compared to USD 106.3 million a year ago. Basic earnings per share from continuing operations was USD 2.15 compared to USD 2.12 a year ago. Diluted earnings per share from continuing operations was USD 2.13 compared to USD 2.11 a year ago.